Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023)

Amirreza Jalilian; Clemens Decristoforo; Melissa Denecke; Philip H Elsinga; Cornelia Hoehr; Aruna Korde; Suzanne E Lapi; Peter J H Scott

doi:10.1186/s41181-023-00224-0

Proceedings of international symposium of trends in radiopharmaceuticals 2023 (ISTR-2023)

EJNMMI Radiopharm Chem. 2023 Nov 10;8(1):39. doi: 10.1186/s41181-023-00224-0.

Authors

Amirreza Jalilian¹, Clemens Decristoforo², Melissa Denecke¹, Philip H Elsinga³, Cornelia Hoehr⁴, Aruna Korde¹, Suzanne E Lapi⁵, Peter J H Scott⁶

Affiliations

¹ Division of Physical and Chemical Sciences, International Atomic Energy Agency, Vienna, Austria.
² Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
³ Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands.
⁴ Life Sciences Division, TRIUMF, Vancouver, Canada.
⁵ Departments of Radiology and Chemistry, O'Neal Comprehensive Cancer Center at UAB, University of Alabama at Birmingham, Birmingham, AL, USA.
⁶ Department of Radiology, University of Michigan, Ann Arbor, MI, USA. pjhscott@umich.edu.

Abstract

The International Atomic Energy Agency (IAEA) held the 3rd International Symposium on Trends in Radiopharmaceuticals, (ISTR-2023) at IAEA Headquarters in Vienna, Austria, during the week of 16-21 April 2023. This procedural paper summarizes highlights from symposium presentations, posters, panel discussions and satellite meetings, and provides additional resources that may be useful to researchers working with diagnostic and therapeutic radiopharmaceuticals in the academic, government and industry setting amongst IAEA Member States and beyond. More than 550 participants in person from 88 Member States attended the ISTR-2023. Over 360 abstracts were presented from all over the world by a diverse group of global scientists working with radiopharmaceuticals. Given this group of international radiochemists is unique to ISTR (IAEA funding enabled many to attend), there was an invaluable wealth of knowledge on the global state of the radiopharmaceutical sciences present at the meeting. The intent of this Proceedings paper is to share this snapshot from our international colleagues with the broader radiopharmaceutical sciences community by highlighting presentations from the conference on the following topics: Isotope Production and Radiochemistry, Industrial Insights, Regional Trends, Training and Education, Women in the Radiopharmaceutical Sciences, and Future Perspectives and New Initiatives. The authors of this paper are employees of IAEA, members of the ISTR-2023 Organizing Committee and/or members of the EJNMMI Radiopharmacy and Chemistry Editorial Board who attended ISTR-2023. Overall, ISTR-2023 fostered the successful exchange of scientific ideas around every aspect of the radiopharmaceutical sciences. It was well attended by a diverse mix of radiopharmaceutical scientists from all over the world, and the oral and poster presentations provided a valuable update on the current state-of-the-art of the field amongst IAEA Member States. Presentations as well as networking amongst the attendees resulted in extensive knowledge transfer amongst the various stakeholders representing 88 IAEA Member States. This was considered particularly valuable for attendees from Member States where nuclear medicine and the radiopharmaceutical sciences are still relatively new. Since the goal is for the symposium series to be held every four years; the next one is anticipated to take place in 2027.

Publication types

Review